ARYA SCIENCES ACQUISITION-A (ARYD) Stock News

USA - NASDAQ:ARYD - KYG316591083 - Common Stock

6.64 USD

-2.32 (-25.92%)

Last: 7/31/2024, 8:22:11 PM

8 USD

+1.36 (+20.48%)

After Hours: 7/31/2024, 8:22:11 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ARYD Latest News, Press Relases and Analysis

All

Press Releases

a year ago - By: Adagio Medical, Inc.

Adagio Medical Announces the Closing of the Business Combination with ARYA IV, Creating a Publicly Traded Company Focused on the Innovative Technologies for Treatment of Cardiac Arrhythmias

1 years ago - By: GENENTA SCIENCE SPA - Mentions: GNTA SQZ

Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider

2 years ago - By: Seeking Alpha

Adagio Medical to go public in $113M deal with SPAC ARYA Sciences (NASDAQ:ARYD)

2 years ago - By: Adagio Medical, Inc.

Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies

4 years ago - By: Benzinga - Mentions: GNTA MIST OPK EDI ...

Stocks That Hit 52-Week Lows On Friday

4 years ago - By: Benzinga - Mentions: FOLD

Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall

4 years ago - By: ARYA Sciences Acquisition Corp IV

News Image

ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus’ Gene Therapy Business Due to Market Conditions

4 years ago - By: Zacks Investment Research - Mentions: REGN ALKS FOLD

Amicus (FOLD) Stock Down on Q3 Earnings and Revenue Miss

4 years ago - By: Zacks Investment Research - Mentions: REGN HZNP FOLD

Amcius (FOLD) to Spin-Off Gene Therapy Arm, Form New Firm With ARYA